Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Exchange Rate Effect: 2024-2025

Historic Exchange Rate Effect for Ani Pharmaceuticals (ANIP) over the last 1 years, with Sep 2025 value amounting to $576,000.

  • Ani Pharmaceuticals' Exchange Rate Effect rose 868.00% to $576,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $725,000, marking a year-over-year change of. This contributed to the annual value of -$470,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Exchange Rate Effect is $576,000, which was down 31.51% from $841,000 recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Exchange Rate Effect ranged from a high of $841,000 in Q2 2025 and a low of -$395,000 during Q4 2024.
  • Over the past 2 years, Ani Pharmaceuticals' median Exchange Rate Effect value was -$75,000 (recorded in 2024), while the average stood at $130,000.
  • Data for Ani Pharmaceuticals' Exchange Rate Effect shows a peak YoY skyrocketed of 868.00% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows Ani Pharmaceuticals' Exchange Rate Effect stood at -$395,000 in 2024, then spiked by 868.00% to $576,000 in 2025.
  • Its Exchange Rate Effect stands at $576,000 for Q3 2025, versus $841,000 for Q2 2025 and -$297,000 for Q1 2025.